CTSH and breast cancer: Although no data are available on the role of cathepsin H in MMTV-PymT breast cancer progression, cathepsin H depletion significantly impairs the establishment and maintenance of tumour vasculature and reduces the tumour burden in the RIP1-Tag2 model of pancreatic islet carcinogenesis [268].